Gofen & Glossberg LLC Biogen Inc. Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
A detailed history of Gofen & Glossberg LLC transactions in Biogen Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 745 shares of BIIB stock, worth $104,545. This represents 0.01% of its overall portfolio holdings.
Number of Shares
745Holding current value
$104,545% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,006Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.35 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.25 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.04 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.04 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$519 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...